Your browser doesn't support javascript.
loading
Impact of obesity as an independent risk factor for the development of renal injury: implications from rat models of obesity.
McPherson, Kasi C; Shields, Corbin A; Poudel, Bibek; Fizer, Brianca; Pennington, Alyssa; Szabo-Johnson, Ashley; Thompson, Willie L; Cornelius, Denise C; Williams, Jan M.
Afiliação
  • McPherson KC; Department of Pharmacology and Toxicology, University of Mississippi Medical Center, Jackson, Mississippi.
  • Shields CA; Department of Pharmacology and Toxicology, University of Mississippi Medical Center, Jackson, Mississippi.
  • Poudel B; Department of Pharmacology and Toxicology, University of Mississippi Medical Center, Jackson, Mississippi.
  • Fizer B; Department of Pharmacology and Toxicology, University of Mississippi Medical Center, Jackson, Mississippi.
  • Pennington A; Department of Pharmacology and Toxicology, University of Mississippi Medical Center, Jackson, Mississippi.
  • Szabo-Johnson A; Department of Pharmacology and Toxicology, University of Mississippi Medical Center, Jackson, Mississippi.
  • Thompson WL; Department of Pharmacology and Toxicology, University of Mississippi Medical Center, Jackson, Mississippi.
  • Cornelius DC; Department of Pharmacology and Toxicology, University of Mississippi Medical Center, Jackson, Mississippi.
  • Williams JM; Department of Emergency Medicine, University of Mississippi Medical Center , Jackson, Mississippi.
Am J Physiol Renal Physiol ; 316(2): F316-F327, 2019 02 01.
Article em En | MEDLINE | ID: mdl-30539649
ABSTRACT
Diabetes and hypertension are the major causes of chronic kidney disease (CKD). Epidemiological studies within the last few decades have revealed that obesity-associated renal disease is an emerging epidemic and that the increasing prevalence of obesity parallels the increased rate of CKD. This has led to the inclusion of obesity as an independent risk factor for CKD. A major complication when studying the relationship between obesity and renal injury is that cardiovascular and metabolic disorders that may result from obesity including hyperglycemia, hypertension, and dyslipidemia, or the cluster of these disorders [defined as the metabolic syndrome, (MetS)] also contribute to the development and progression of renal disease. The associations between hyperglycemia and hypertension with renal disease have been reported extensively in patients suffering from obesity. Currently, there are several obese rodent models (high-fat diet-induced obesity and leptin signaling dysfunction) that exhibit characteristics of MetS. However, the available obese rodent models currently have not been used to investigate the impact of obesity alone on the development of renal injury before hypertension and/or hyperglycemia. Therefore, the aim of this review is to describe the incidence and severity of renal disease in these rodent models of obesity and determine which models are suitable to study the independent effects obesity on the development and progression of renal disease.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Síndrome Metabólica / Nefropatias / Obesidade Tipo de estudo: Etiology_studies / Prognostic_studies / Risk_factors_studies Limite: Animals / Humans Idioma: En Revista: Am J Physiol Renal Physiol Assunto da revista: FISIOLOGIA / NEFROLOGIA Ano de publicação: 2019 Tipo de documento: Article País de publicação: EEUU / ESTADOS UNIDOS / ESTADOS UNIDOS DA AMERICA / EUA / UNITED STATES / UNITED STATES OF AMERICA / US / USA

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Síndrome Metabólica / Nefropatias / Obesidade Tipo de estudo: Etiology_studies / Prognostic_studies / Risk_factors_studies Limite: Animals / Humans Idioma: En Revista: Am J Physiol Renal Physiol Assunto da revista: FISIOLOGIA / NEFROLOGIA Ano de publicação: 2019 Tipo de documento: Article País de publicação: EEUU / ESTADOS UNIDOS / ESTADOS UNIDOS DA AMERICA / EUA / UNITED STATES / UNITED STATES OF AMERICA / US / USA